59338-0775-10FERAHEME 510 mg/17 mL, 10 vials Diagnosis codes (ICD-10)4 D50.0 Blood loss (chronic) D50.1 Sideropenic dysphagia D50.8 Poor iron absorption D50.9 Iron deficiency anemia, unspecified Confirm iron deficiency before using the following codes:
Medicaid covers appropriate administration codes when billed with Q0138, Q0139, J1750, J1756, or J2916 on the same day of service. • Feraheme® (ferumoxytol) Injection for intravenous (IV) use is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease.
59338-0775-01FERAHEME 510 mg/17 mL, 1 vial 59338-0775-10FERAHEME 510 mg/17 mL, 10 vials Diagnosis codes (ICD-10)4 D50.0 Blood loss (chronic) D50.1 Sideropenic dysphagia D50.8 Poor iron absorption D50.9 Iron deficiency anemia, unspecified Confirm iron deficiency before using the following codes:
The dosage is expressed in terms of mg of elemental iron, with each mL of Feraheme containing 30 mg of elemental iron. Evaluate the hematologic response (hemoglobin, ferritin, iron and transferrin saturation) at least one month following the second Feraheme infusion.
Feraheme is in a class of medicines called IV iron replacement products. It is used to treat iron-deficiency anemia―a condition in which there is a lower than normal number of oxygen-carrying red blood cells because of too little iron.
Feraheme – Feraheme® (ferumoxytol injection) for intravenous (IV) use indicated for the treatment of iron deficiency anemia. See Indication and Important Safety Information.
ICD-10-CM Code for Iron deficiency E61. 1.
ICD-10 code D50. 9 for Iron deficiency anemia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Medicare does not have a National Coverage Determination (NCD) for Feraheme® (ferumoxytol) or for Injectafer® (ferric carboxymaltose).
Ferumoxytol is used to treat iron deficiency anemia (a lack of red blood cells caused by having too little iron in the body). Ferumoxytol injection is used in people with chronic kidney disease, or in people unable to take oral iron (by mouth) or who have not responded well to oral iron.
2022 ICD-10-CM Diagnosis Code E61. 1: Iron deficiency.
ICD-10-CM Diagnosis Code D50 D50.
ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Abstract. Microcytic anemia is defined as the presence of small, often hypochromic, red blood cells in a peripheral blood smear and is usually characterized by a low MCV (less than 83 micron 3). Iron deficiency is the most common cause of microcytic anemia.
Ferritin, iron and either iron binding capacity or transferrin are useful in the differential diagnosis of iron deficiency, anemia, and for iron overload conditions.
As the name implies, iron deficiency anemia is due to insufficient iron. Without enough iron, your body can't produce enough of a substance in red blood cells that enables them to carry oxygen (hemoglobin). As a result, iron deficiency anemia may leave you tired and short of breath.
The 2022 edition of ICD-10-CM T45.4X5A became effective on October 1, 2021.
T45- Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
Ferumoxytol (Feraheme) Ferumoxytol is covered for the FDA-approved ages – 18 years of age and older. a.
The recommended Feraheme dose may be readministered to patients with persistent or recurrent iron deficiency anemia. For patients receiving hemodialysis, administer Feraheme once the blood pressure is stable and the patient has completed at least one hour of hemodialysis.
Providers must bill with HCPCS code Q0138 : Ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for ESRD on dialysis), injection (Feraheme).
Medicaid and NCHC shall cover ferumoxytol only for the following FDA-Approved Indications: